OSMOLOGY AND PHARMACODYNAMICS.
نویسندگان
چکیده
منابع مشابه
Topiramate: pharmacokinetics and pharmacodynamics.
Topiramate is a structurally novel anti-epileptic drug with at least 3 postulated mechanisms of action including: 1) potentiation of GABA responses, 2) impairment of AMPA/kainate glutamate receptors and 3) suppression of high frequency action potential firing. It has a favourable pharmacokinetic profile with rapid absorption, good bio-availability, linear pharmacokinetics, relatively long half-...
متن کاملSystems Pharmacology and Pharmacodynamics
Reviewed by Piet H. van der Graaf In 2008 and 2010, the National Institute of General Medical Sciences of the National Institutes of Health sponsored two workshops that resulted in the 2011 white paper “Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Mechanisms,” which is widely accepted to be a milestone marking t...
متن کاملMacrolides: pharmacokinetics and pharmacodynamics.
Three pharmacokinetic/pharmacodynamic parameters--(i) the peak concentration to the minimum inhibitory concentration ratio (C(max)/MIC); (ii) the area under the concentration-time curve to MIC ratio (AUC(24h)/MIC); and (iii) the time the concentration exceeds the MIC (T>MIC)--are important predictors of the clinical efficacy of antibiotics. For antibiotics with pronounced concentration-dependen...
متن کاملrmacokinetics, and Pharmacodynamics
ownload phase I trial examined the safety, pharmacokinetics, and pharmacodynamics of MLN8054, an oral, ve, small-molecule inhibitor of Aurora A kinase. Patients with advanced solid tumors received increasses of MLN8054 in 28-day cycles until dose-limiting toxicity (DLT) was seen in ≥2 of 3-6 patients in a . For the 10-mg and 20-mg cohorts, treatment was administered once daily on days 1 to 5 an...
متن کاملPharmacokinetics and Pharmacodynamics
J Clin Pharmacol xxxx;xx:x-x 1 The pharmacokinetics and pharmacodynamics of rivastigmine were compared in Japanese and white healthy participants who were given ascending single doses of the novel rivastigmine transdermal patch. Rivastigmine patch strengths were 4.6 mg/24 h (5 cm, 9 mg rivastigmine loaded dose), 9.5 mg/24 h (10 cm, 18 mg), and 13.3 mg/24 h (15 cm, 27 mg) (per label) or 7.0 mg/2...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA: The Journal of the American Medical Association
سال: 1905
ISSN: 0098-7484
DOI: 10.1001/jama.1905.92500300016001d